US Patent and Trade­mark Of­fice to hear patent chal­lenge over ex­per­i­men­tal seizure treat­ment

The US Patent and Trade­mark Of­fice (USP­TO) is tak­ing a sec­ond look at a patent it grant­ed Ovid Ther­a­peu­tics around meth­ods for treat­ing seizures fol­low­ing a chal­lenge from Mar­i­nus.

The USP­TO’s Patent Tri­al and Ap­peal Board grant­ed Mar­i­nus’ pe­ti­tion seek­ing post-grant re­view of Ovid’s Patent No. 11,395,817, al­so known as the ‘817 patent. It cov­ers “meth­ods and com­po­si­tions” for treat­ing epilep­tic dis­or­ders, in­clud­ing a dif­fi­cult-to-treat con­di­tion called sta­tus epilep­ti­cus (SE).

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER